Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamibarotene Plus Chemotherapy in Advanced NSCLC
NCT01337154Phase 2Terminated
- Sponsor
- LadRx
- Start
- Apr 2011
- Primary completion
- Jun 2013
- Modality
- Orthosteric Ligands
- Countries
- 6
01
Overview
A Phase 2 trial of tamibarotene in non-small cell lung cancer (NSCLC), sponsored by LadRx. Started Apr 2011; status: terminated.
02
Drugs
tamibarotene
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01337154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01337154.